March 8

AHRP Letter to FDA Commissioner-Themirosal

Promoting Openness, Full Disclosure, and Accountability  
March 8, 2006

Dr. Andrew vonEschenbach
FDA Commissioner

Dear Dr. vonEschenbach:

A study by Geier and Geier published in the March 1, 2006 issue of the Journal of American Physicians and Surgeons documents a decrease in neurodevelopmental disorders in children following removal of thimerosal from American childhood vaccines.

The Alliance for Human Research Protection (AHRP) is requesting information about whether any childhood vaccines still remain available for use in the United States. Our concern relates to the published charge of Robert Kennedy, Jr., that "the government continues to ship vaccines preserved with thimerosal to developing countries — some of which are now experiencing a sudden explosion in autism rates."

Our questions are three-fold.
1. Has the FDA issued an official recall of the stock of vaccines containing thimerosal as a preservative for use in the United States?

2. If so, does the FDA have a list of vaccine lot numbers to which pediatricians and general medical practitioners can refer to check their current supply of vaccines on hand?

3. Is there any truth to the Kennedy claim that our government is shipping vaccines preserved with thimerosal to developing countries?

Thank you for your kind and expeditious response.


Vera Hassner Sharav
President, Alliance for Human Research Protection

Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.

You may also like

April 13, 2023

Dear Supporter of Freedom, Autonomy and the Right to Voluntary Informed Consent! Please join me on Wednesday, April

Read More
Join Robert F Kennedy Jr. – April 19 in Boston

January 26, 2023

Holocaust survivors, children and grandchildren of survivors express their concerns about the ominous current events. These survivors

Read More
Vera Sharav’s documentary “Never Again is Now Global” now available